- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT05225064
Increasing COVID-19 Vaccine Uptake in Developing Countries (Bihar)
Studieoversigt
Status
Betingelser
Detaljeret beskrivelse
The goal of the study is to identify strategies that best promote and support COVID vaccine uptake in developing countries, we propose to test a range of scalable social and behavioural interventions. This could help policy makers design and employ interventions that are effective. This is especially valuable in resource constrained contexts where funds and institutional resources can be diverted towards interventions that have proven to work.
In Bihar the intervention will be village-level social mobilization involving community promotion, including in-person vaccine reinforcement, and household-level social mobilization. Some treatment villages will receive household- level interventions with varying intensity (different proportion of households will be visited). There will also an accompanying mask distribution campaign during household visits where the importance of mask-wearing as a complement to vaccine use will be explained.
This ClinicalTrials entry contains results only for the study in Bihar.
Undersøgelsestype
Tilmelding (Faktiske)
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Bihar
-
Patna, Bihar, Indien, 800001
- Project Concern International
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Lives in study village
Exclusion Criteria:
- Does not live in study village
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Dobbelt
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Ingen indgriben: Control
No vaccine or mask promotion, but access to vaccines increased to match access in intervention villages
|
|
|
Eksperimentel: Village-level vaccine clinics with monetary, non-monetary, or no incentive
Village-level vaccine clinics with monetary, non-monetary, or no incentive.
Villages are cross-randomized to grocery coupon, food ration, no incentive, or grocery coupon to both community member and community health worker after the community member has received a vaccination.
|
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
|
Eksperimentel: Household-level vaccination with monetary or no incentive
Household-level vaccination with monetary incentive or no incentive.
Villages are cross-randomized to grocery coupon or no incentive upon receiving vaccination
|
Individuals will be provided with a guaranteed cash payment, entry into a cash lottery, or guaranteed gift of food if they are vaccinated
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
|
Eksperimentel: Village-level vaccination without incentive, plus mask promotion
Individuals are encourage to attend village-level vaccine clinics but not given any incentive.
Mask distribution and reinforcement activities are conducted in villages at a similar time as vaccine promotion.
|
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
Individuals are given cloth masks
Individuals who are not wearing masks over their mouth and nose are stopped in public places and encouraged to wear a mask
|
|
Eksperimentel: Village-level vaccination without incentive
Individuals are encourage to attend village-level vaccine clinics but not given any incentive.
|
Vaccines are conducted at the household-level rather than the village-level
Village-level social mobilization campaign to be vaccinated
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Percent of individuals who receive the first, second, or third dose of covid vaccine
Tidsramme: up to 4 weeks (endline may vary depending on estimated uptake rates)
|
Prevalence of vaccination with difference doses
|
up to 4 weeks (endline may vary depending on estimated uptake rates)
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 2000031541
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Vaccinationsafslag
-
University of Massachusetts, WorcesterRekruttering
-
National Cancer Institute (NCI)AfsluttetHPV16-anitbody-niveauer efter vaccination | HPV18-antistofniveauer efter vaccinationUganda
-
Université de Reims Champagne-ArdenneRekruttering
-
University of EssexUniversity of Southern California; Kingston University; Department of Health...AfsluttetVaccinationDet Forenede Kongerige
-
China National Biotec Group Company LimitedPeking University; Beijing Institute of Biological Products Co Ltd.; Sichuan... og andre samarbejdspartnereAfsluttet
-
China National Biotec Group Company LimitedSichuan Center for Disease Control and PreventionAfsluttet
-
Emory UniversityMerck Sharp & Dohme LLCAfsluttetVaccinationForenede Stater
-
Columbia UniversityAfsluttet
-
Children's Hospital Medical Center, CincinnatiRekrutteringVaccinationForenede Stater
-
University of EssexUniversity of Southern California; Kingston University; Department of Health...AfsluttetVaccinationDet Forenede Kongerige
Kliniske forsøg med Incentives to be vaccinated
-
Gérard AmarencoAfsluttetMultipel sclerose | Gangforstyrrelser, neurologiske | Urininkontinens, UrgeFrankrig
-
University of Alabama at BirminghamNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeKræft | Familie medlemmerForenede Stater
-
University of Alabama at BirminghamAfsluttetKræft | FamilieplejereForenede Stater
-
Tampere UniversityTurku University Hospital; Helsinki University Central Hospital; Oulu University... og andre samarbejdspartnereAktiv, ikke rekrutterendeDupuytren KontrakturFinland